Salix Pharmaceuticals Announces 1Q2007 Financial Results Conference Call and Webcast.RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :SLXP) today announced that the Company will report first quarter ended March 31, 2007 financial results before the market opens on Tuesday, May 8, 2007. The Company will host a conference call at 9:00 a.m. ET, on Tuesday, May 8, 2007. Interested parties can access the conference call by way of web cast or telephone. The live web cast will be available at http://www.salix.com. A replay of the web cast will be available at the same location. The telephone numbers to access the live conference call are (800) 238-9007 (U.S. and Canada) or (719) 457-2622 (international.) The access code for the call is 2447315. Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's gastroenterology specialty sales and marketing team. Salix markets COLAZAL([R])(balsalazide) Capsules 750 mg, XIFAXAN([R])(rifaximin) Tablets, OSMOPREP[TM] (sodium phosphate monobasic monobasic /mono·ba·sic/ (-ba´sik) having but one atom of replaceable hydrogen. mon·o·ba·sic adj. 1. Having only one hydrogen ion to donate to a base in an acid-base reaction. monohydrate mon·o·hy·drate n. A compound, such as calcium chloride monohydrate, that contains one molecule of water. , USP, and sodium phosphate dibasic dibasic /di·ba·sic/ (di-ba´sik) containing two replaceable hydrogen atoms, or furnishing two hydrogen ions. di·ba·sic adj. 1. Containing two replaceable hydrogen atoms. 2. anhydrous, USP) Tablets, MOVIPREP([R])(PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate a·scor·bate n. A salt of ascorbic acid. ascorbate a compound or derivative of ascorbic acid. See also sodium ascorbate. and ascorbic acid for Oral Solution), VISICOL([R])Tablets (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous), PEPCID([R]) (famotidine) for Oral Suspension, DIURIL([R])(chlorothiazide chlorothiazide /chlo·ro·thi·a·zide/ (klor?o-thi´ah-zid) a thiazide diuretic used in the form of the base or the sodium salt to treat hypertension and edema. ) Suspension,AZASAN([R])(Azathioprine azathioprine: see metabolite. Tablets, USP), ANUSOL-HC([R]) (Hydrocortisone Cream, USP) and PROCTOCORT([R])(Hydrocortisone Cream, USP). Balsalazide disodium tablets, Granulated Mesalamine, SANVAR([R]) (600 ug vials vapreotide acetate powder) and Xifaxan are under development for additional indications. Salix trades on the NASDAQ Market under the ticker symbol "SLXP." For more information please contact the Company at 919-862-1000 or visit our web site at www.salix.com. Information on our web site is not incorporated in our SEC filings. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion